About 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine
2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine (PubChem CID 136536708) has the molecular formula C15H15ClFN3O2
and a molecular weight of 323.75 g/mol. Its IUPAC name is 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine.
Analyze 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine?
The IUPAC name of 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine (CID 136536708) is 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine.
What is the SMILES notation for 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine?
The canonical SMILES for 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine is Fc1ccc(C2CN(c3nnc(C4CC4)o3)CCO2)c(Cl)c1.
What is the InChIKey of 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine?
The InChIKey is YENNTELUQYSGKS-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H15ClFN3O2/c16-12-7-10(17)3-4-11(12)13-8-20(5-6-21-13)15-19-18-14(22-15)9-1-2-9/h3-4,7,9,13H,1-2,5-6,8H2.
What are the key properties of 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine?
2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine has a molecular weight of 323.75 g/mol, XLogP of 3.32, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2-chloro-4-fluorophenyl)-4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)morpholine is sourced from PubChem (CID 136536708), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).